AR026062A1 - Tratamiento de desordenes oculares - Google Patents

Tratamiento de desordenes oculares

Info

Publication number
AR026062A1
AR026062A1 ARP000105450A ARP000105450A AR026062A1 AR 026062 A1 AR026062 A1 AR 026062A1 AR P000105450 A ARP000105450 A AR P000105450A AR P000105450 A ARP000105450 A AR P000105450A AR 026062 A1 AR026062 A1 AR 026062A1
Authority
AR
Argentina
Prior art keywords
treatment
eye disorders
disorders
eye
Prior art date
Application number
ARP000105450A
Other languages
English (en)
Spanish (es)
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of AR026062A1 publication Critical patent/AR026062A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ARP000105450A 1999-10-19 2000-10-17 Tratamiento de desordenes oculares AR026062A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99120678 1999-10-19

Publications (1)

Publication Number Publication Date
AR026062A1 true AR026062A1 (es) 2002-12-26

Family

ID=8239225

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000105450A AR026062A1 (es) 1999-10-19 2000-10-17 Tratamiento de desordenes oculares

Country Status (13)

Country Link
US (2) US6534541B1 (enExample)
EP (1) EP1225890B1 (enExample)
JP (1) JP2003512324A (enExample)
AR (1) AR026062A1 (enExample)
AT (1) ATE285764T1 (enExample)
AU (1) AU766001B2 (enExample)
CA (1) CA2384690C (enExample)
DE (1) DE60017174T2 (enExample)
DK (1) DK1225890T3 (enExample)
ES (1) ES2234708T3 (enExample)
NZ (1) NZ518164A (enExample)
PT (1) PT1225890E (enExample)
WO (1) WO2001028553A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2237163T3 (es) 1998-10-01 2005-07-16 Novartis Ag Nuevas formulaciones orales de revastigmina de liberacion controlada.
US9993558B2 (en) 2004-10-01 2018-06-12 Ramscor, Inc. Sustained release eye drop formulations
US8541413B2 (en) * 2004-10-01 2013-09-24 Ramscor, Inc. Sustained release eye drop formulations
WO2009022345A1 (en) * 2007-08-14 2009-02-19 Yissum Research Development Company Of The Hebrew University Of Jerusalem Phenyl carbamates for the treatment of multiple sclerosis
US12478503B2 (en) 2009-05-18 2025-11-25 Glaukos Corporation Implants with controlled drug delivery features and methods of using same
US10206813B2 (en) 2009-05-18 2019-02-19 Dose Medical Corporation Implants with controlled drug delivery features and methods of using same
WO2011151359A1 (en) 2010-06-02 2011-12-08 Noscira, S.A. Combined treatment with a cholinesterase inhibitor and a thiadiazolidinedione derivative
CN107417574B (zh) * 2017-03-21 2019-12-03 浙江省医学科学院 2,4-双取代苯乙酮化合物及其旋光异构体、药学上可接受的盐及应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL74497A (en) 1985-03-05 1990-02-09 Proterra Ag Pharmaceutical compositions containing phenyl carbamate derivatives and certain phenyl carbamate derivatives
HU201906B (en) * 1987-03-04 1991-01-28 Sandoz Ag Process for producing phenyl-carbamate derivative and acid additional salts and pharmaceutical compositions containing them
US4900748A (en) 1988-03-04 1990-02-13 The United States Of America As Represented By The Department Of Health And Human Services Carbamates related to (-)-physostigmine as cholinergic agents
JP3708957B2 (ja) 1991-09-26 2005-10-19 アメリカ合衆国 (−)−エゼロリン、(−)−n1−ノルエゼロリンおよび(−)−n1−ベンジルノルエゼロリンの置換フェンゼリンおよびフェニルカルバミン酸塩:特異的アセチルコリンエステラーゼ阻害薬としての使用
ES2206449T3 (es) 1991-09-26 2004-05-16 The Government Of The Usa As Represented By The Secretary Of Department Of Health And Human Services Inhibidores de colinesterasas, composiciones farmaceuticas y sus usos.
AU1138097A (en) * 1995-12-22 1997-07-17 Alcon Laboratories, Inc. Combinations of prostaglandins and miotics for lowering intraocular pressure

Also Published As

Publication number Publication date
ES2234708T3 (es) 2005-07-01
US6835748B2 (en) 2004-12-28
PT1225890E (pt) 2005-05-31
JP2003512324A (ja) 2003-04-02
NZ518164A (en) 2003-10-31
EP1225890B1 (en) 2004-12-29
DK1225890T3 (da) 2005-04-04
WO2001028553A1 (en) 2001-04-26
DE60017174T2 (de) 2005-12-22
US20030119832A1 (en) 2003-06-26
US6534541B1 (en) 2003-03-18
AU2834901A (en) 2001-04-30
CA2384690C (en) 2010-08-17
DE60017174D1 (de) 2005-02-03
ATE285764T1 (de) 2005-01-15
EP1225890A1 (en) 2002-07-31
AU766001B2 (en) 2003-10-09
CA2384690A1 (en) 2001-04-26

Similar Documents

Publication Publication Date Title
GB0007193D0 (en) Treatment of movrmrnt disorders
HUP0400914A3 (en) Methods of treatment of mitochondrial disorders
DE69903543D1 (de) Formulierungen zur behandlung von magen-speiseröhren reflux
FI20000863A0 (fi) Uusi hoitomenetelmä
NO20021845D0 (no) Behandling av sövnforstyrrelser under anvendelse av desloratadin
NO20026263L (no) Sulfonyl-pyrrolidin-derivater anvendelige for behandling av neurologiske forstyrrelser
ID30276A (id) Metode untuk mengobati gangguan-gangguan seksual
NO20041386L (no) Kombinasjoner for bahandling av immunoinflammatoriske forstyrrelser
DE60204466D1 (de) Integrinhemmer zur behandlung von augenkrankheiten
NO20020062D0 (no) Behandling av nevrotiske forstyrrelser
EP1117431A4 (en) TREATMENT OF ACIDOSIS
ID27214A (id) Triazolopiridina untuk pengobatan gangguan trombosis
NO20013337D0 (no) Ny behandling
AR026062A1 (es) Tratamiento de desordenes oculares
AU7106300A (en) Treatment of skin disorders
PT1268482E (pt) Piranoindois para o tratamento de glaucoma
ID30458A (id) Osanetan dalam pengobatan gangguan jiwa
EE200200670A (et) S-metüüldihüdroziprasidoon psühhiaatriliste ja silmahaiguste raviks
NO20012612D0 (no) Isonipecotamider for behandling av integren-formidlede lidelser
PT1200447E (pt) Oxazinocarbazoles para o tratamento de doencas do snc
IS6020A (is) S-nítrósóþíól til meðferðar við blóðrásartruflunum
DE60025705D1 (de) Antikonvulsive derivate zur behandlung von essentiellem tremor
DK82798A (da) Treatment of GABA-uptake related disorders
NO20041396L (no) Fremgangsmåte for behandling av hudlidelser
NO20014476D0 (no) Behandling av hiatial hernia

Legal Events

Date Code Title Description
FB Suspension of granting procedure